Discontinued — last reported Q1 '22

Non-Current Assets

Equity securities

Medtronic Equity securities decreased by 12.3% to $50.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 56.3%, from $32.00M to $50.00M. This decline may warrant attention — for this metric, higher values are generally preferred.

Analysis

StatementBalance Sheet Statement
SectionNon-Current Assets
CategoryCapital Allocation
SignalHigher is better
VolatilityVolatile
First reportedQ1 2019
Last reportedQ1 2022

How to read this metric

An increase reflects positive market performance of the underlying investments or additional capital deployment into equities.

Detailed definition

This represents the fair market value of the company's investment portfolio consisting of equity securities in other ent...

Peer comparison

Standard for companies with large corporate venture arms or significant treasury investment portfolios.

Metric ID: ins_equity_securities

Historical Data

8 periods
 Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Value$28.00M$311.00M$311.00M$32.00M$140.00M$50.00M$57.00M$50.00M
QoQ Change>999%+0.0%-89.7%+337.5%-64.3%+14.0%-12.3%
YoY Change+400.0%-83.9%-81.7%+56.3%
Range$28.00M$311.00M
CAGR+39.3%
Avg YoY Growth+72.7%
Median YoY Growth-12.7%

Frequently Asked Questions

What is Medtronic's equity securities?
Medtronic (MDT) reported equity securities of $50.00M in Q1 2026.
How has Medtronic's equity securities changed year-over-year?
Medtronic's equity securities increased by 56.3% year-over-year, from $32.00M to $50.00M.
What does equity securities mean?
The current market value of the company's stock investments in other businesses.